Search Articles

Found 1,803 articles

  • Immutep appoints leading oncologists to its Clinic

    Immutep appoints leading oncologists to its Clinical Advisory Board

    • 19 May 2022
    • Editor

    Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, announces today the appointment of four new members to the Company's Clinical Advisory Board (CAB).

  • MSD proud to be recognised as a family friendly wo

    MSD proud to be recognised as a family friendly workplace

    • 18 May 2022
    • Editor

    MSD has today been named a Family Friendly Workplace in accordance with the National Work + Family Standards. Established by UNICEF Australia and Parents at Work, the Family Friendly Workplaces certification framework encourages employers to benchmark their own internal standards against nationally recognised best practices.

  • AstraZeneca signs licence agreement with RQ Biotec

    AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19

    • 18 May 2022
    • Editor

    AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd (RQ Bio) for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2, the virus that causes COVID-19.

  • Pfizer and BioNTech Granted U.S. Emergency Use Aut

    Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age

    • 18 May 2022
    • Editor

    Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose after completion of the primary series of the Pfizer-BioNTech COVID-19 Vaccine in children 5 through 11 years of age.

  • Thermo Fisher Scientific’s Clinical Research Busin

    Thermo Fisher Scientific’s Clinical Research Business Honored in CRO Leadership Awards

    • 18 May 2022
    • Editor

    The PPD clinical research business of Thermo Fisher Scientific has been recognized for excellence in the 2022 CRO Leadership Awards. This is the 11th consecutive year the business has been honored through this award program, which is based on a survey of pharmaceutical and biotech professionals conducted for Clinical Leader and Life Science Leader magazines.

  • BeiGene Strengthens European Presence with the Ope

    BeiGene Strengthens European Presence with the Opening of Regional Office in Basel, Switzerland

    • 17 May 2022
    • Editor

    BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, yesterday announced the opening of a new regional office in Basel, Switzerland. BeiGene has built a European organization, including commercial and clinical teams, and this new location will serve as a hub for the company’s operations in the region.

  • AbbVie and Cugene Announce Collaboration in Autoim

    AbbVie and Cugene Announce Collaboration in Autoimmune Diseases

    • 16 May 2022
    • Editor

    AbbVie (NYSE: ABBV) and Cugene Inc., a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines to treat autoimmune disease and cancer, today announced an exclusive worldwide license option agreement for CUG252, a potential best-in-class Treg-selective IL-2 mutein, as well as other novel IL-2 muteins, for the potential treatment of autoimmune and inflammatory diseases.

  • Coulter Partners announces two additional appointm

    Coulter Partners announces two additional appointments in Italy

    • 16 May 2022
    • Editor

    Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, announces two additional appointments to its new Milan office.

  • GSK Australia continues bridging skills gap betwee

    GSK Australia continues bridging skills gap between academic and industry with new cohort of Graduate Researchers

    • 16 May 2022
    • Editor

    GSK Australia is delighted to announce the second year of its Graduate Researcher Program. The 2022 program welcomes a new cohort of six PhD graduates who are working across GSK projects, following the success of the inaugural program last year.

  • SciRhom Announces Addition to the Management Team

    SciRhom Announces Addition to the Management Team

    • 13 May 2022
    • Editor

    To optimize management expertise for the next phase of development, Dr. Jan Poth will assume the role of Chief Executive Officer in advancing the company’s proprietary anti-iRhom2 antibodies.

  • Richard Park appointed to Global Head of Client Re

    Richard Park appointed to Global Head of Client Relations & Business Development

    • 13 May 2022
    • Editor

    evitria AG, a Zurich, Switzerland-based contract research, development, and manufacturing organization focused on transient recombinant antibody and protein production, announced that former Director of Client Relations, Richard Park, has been appointed Global Head of Client Relations and Business Development.

  • Coulter Partners expands its global team with key

    Coulter Partners expands its global team with key appointments and a new office in Italy

    • 13 May 2022
    • Editor

    Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, announces the opening of its new office in Milan and two additional key appointments. Francesca Lazzarin joins as Executive Director and Giuliana Milioto as Research Associate. We will be announcing two further appointments next week.

  • Weekly Life Science News Round Up: 9th – 13th May

    Weekly Life Science News Round Up: 9th – 13th May

    • 13 May 2022
    • Editor

    A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Devices sectors from 9th-13th May.

  • This move is important to you. To support you to get that job, PharmiWeb.Jobs are delighted to announce they’ve partnered with CareerJay

    • 12 May 2022
    • Mike Wood

    This move is important to you. To support you to get that job, PharmiWeb.Jobs are delighted to announce they’ve partnered with CareerJay

  • How to Build Resilience and Reduce Burnout

    How to Build Resilience and Reduce Burnout

    • 12 May 2022
    • CareerJay

    Our work demands us to be mentally alert. There’s not much cruise control or autopilot in our industry. As a result, we need to be even more aware of self care and balance, to avoid burnout

  • Ian Adamson Joins Maxwellia as Strategic Advisor

    Ian Adamson Joins Maxwellia as Strategic Advisor

    • 12 May 2022
    • Editor

    Maxwellia’s pioneering vision, exponential growth, and media grabbing headlines over the past two years has attracted industry expert Ian Adamson who joins the company as strategic advisor. Ian’s role will be to work with Maxwellia to shape the next phase of pharmacy medicine launches - a process which involves identifying and converting suitable prescription only medicines into versions people can choose to buy under the supervision of a pharmacist.

  • Johnson & Johnson Appoints Thibaut Mongon as CEO D

    Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

    • 12 May 2022
    • Editor

    Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the appointment of Thibaut Mongon as Chief Executive Officer Designate and Paul Ruh as Chief Financial Officer Designate of the future, listed New Consumer Health Company.

  • finnCap appoints Dr Stephen McGarry to strengthen

    finnCap appoints Dr Stephen McGarry to strengthen Life Sciences team

    • 12 May 2022
    • Editor

    finnCap Group is delighted to announce the appointment of Dr. Stephen McGarry as Research Director in its Life Sciences team. Stephen is joining the research team to expand the growth trajectory of the franchise following its strong performance over the last two years.

  • Rejuvenate Biomed appoints life sciences leader Dr

    Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions

    • 12 May 2022
    • Editor

    Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, appoints Dr. Ajit Shetty as Chair of the Board of Directors. As a veteran of the life sciences industry, Dr. Shetty will strengthen the business strategy of this ambitious company through both mentorship and connections.

  • SOLVE FSHD Announces Appointment of Executive Dire

    SOLVE FSHD Announces Appointment of Executive Director Dr. Eva Chin and Venture-Philanthropic Funding Structure

    • 12 May 2022
    • Editor

    Following SOLVE FSHD’s recent acclaimed launch, the organization is pleased to formally announce the appointment of Dr. Eva Chin as the Executive Director. SOLVE FSHD’s Founder, Chip Wilson, has personally committed USD100 million to find a cure for facioscapulohumeral muscular dystrophy (FSHD), a rare disease he was diagnosed with at the age of 32.